AT263759B - Verfahren zur Herstellung von neuen 1-[(5-substituierten)-Furfurylidenamino]-hydantoinen oder -imidazolidonen - Google Patents

Verfahren zur Herstellung von neuen 1-[(5-substituierten)-Furfurylidenamino]-hydantoinen oder -imidazolidonen

Info

Publication number
AT263759B
AT263759B AT843966A AT843966A AT263759B AT 263759 B AT263759 B AT 263759B AT 843966 A AT843966 A AT 843966A AT 843966 A AT843966 A AT 843966A AT 263759 B AT263759 B AT 263759B
Authority
AT
Austria
Prior art keywords
furfurylidenamino
imidazolidones
hydantoins
substituted
preparation
Prior art date
Application number
AT843966A
Other languages
German (de)
English (en)
Original Assignee
Norwich Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharma Co filed Critical Norwich Pharma Co
Application granted granted Critical
Publication of AT263759B publication Critical patent/AT263759B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Food-Manufacturing Devices (AREA)
AT843966A 1965-09-07 1966-09-07 Verfahren zur Herstellung von neuen 1-[(5-substituierten)-Furfurylidenamino]-hydantoinen oder -imidazolidonen AT263759B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US485566A US3415821A (en) 1965-09-07 1965-09-07 1-(5-substituted)furfurylideneamino hydantoins and imidazolidinones

Publications (1)

Publication Number Publication Date
AT263759B true AT263759B (de) 1968-08-12

Family

ID=23928650

Family Applications (1)

Application Number Title Priority Date Filing Date
AT843966A AT263759B (de) 1965-09-07 1966-09-07 Verfahren zur Herstellung von neuen 1-[(5-substituierten)-Furfurylidenamino]-hydantoinen oder -imidazolidonen

Country Status (14)

Country Link
US (1) US3415821A (en, 2012)
AT (1) AT263759B (en, 2012)
BE (1) BE686434A (en, 2012)
BR (1) BR6682681D0 (en, 2012)
CH (1) CH483446A (en, 2012)
DE (1) DE1620093A1 (en, 2012)
DK (1) DK116509B (en, 2012)
FI (1) FI45556C (en, 2012)
FR (1) FR1550961A (en, 2012)
GB (1) GB1097359A (en, 2012)
IL (1) IL26182A (en, 2012)
NL (1) NL147434B (en, 2012)
NO (1) NO118068B (en, 2012)
SE (1) SE303758B (en, 2012)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689654A (en) * 1970-09-14 1972-09-05 Morton Norwich Products Inc Pharmaceutical compositions
US3803136A (en) * 1972-08-23 1974-04-09 Morton Norwich Products Inc 5-hydroxy-1-((5-(substituted phenyl)furfurylidene)amino)hydrantoins
US3857835A (en) * 1974-01-25 1974-12-31 Morton Norwich Products Inc 1-(5-(p-nitro phenyl)furfurylidene) amino)-5,6-dihydrouracil
US4001222A (en) * 1975-10-14 1977-01-04 Morton-Norwich Products, Inc. 3-(Aminoacyl)-1-{[5-(substituted phenyl)furfurylidene]amino}hydantoins and process for their preparation thereof
US4049650A (en) * 1976-10-18 1977-09-20 Morton-Norwich Products, Inc. 1-[[[5-(Substituted phenyl)-2-oxazolyl]methylene]amino]-2,4-imidazolidinediones
DE3565103D1 (en) * 1984-12-29 1988-10-27 Basf Ag Substituted furanes and their precursors
US4861790A (en) * 1987-10-28 1989-08-29 Norwich Eaton Pharmaceuticals, Inc. Use of azumolene for the treatment of malignant hyperthermia
SK279677B6 (sk) * 1991-08-14 1999-02-11 Procter And Gamble Pharmaceuticals Cyklické deriváty močoviny a farmaceutický prostri
DE69230563T2 (de) * 1991-08-14 2000-09-14 Procter & Gamble Pharmaceuticals, Inc. Oxazolidinon-derivate mit antiarrhythmischer und antifibrillatorische wirkung
AU668360B2 (en) * 1991-08-14 1996-05-02 Warner Chilcott Company, Llc Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents
US8975284B2 (en) * 2007-10-09 2015-03-10 Us Worldmeds Llc Co-solvent compositions and methods for improved delivery of dantrolene therapeutic agents
US8536213B2 (en) * 2007-11-16 2013-09-17 Nektar Therapeutics Oligomer-dantrolene conjugates and related compounds
SG11202003452XA (en) 2017-10-20 2020-05-28 Eagle Res Labs Limited Dantrolene prodrugs and methods of their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2746960A (en) * 1955-05-26 1956-05-22 Norwith Pharmacal Company New chemotherapeutic nitrofurans
FR1310188A (en, 2012) * 1960-12-27 1963-03-06
US3076805A (en) * 1962-02-26 1963-02-05 Norwich Pharma Co New 1-(hydroxy(lower) alkyl)-3-(5-nitrofurfurylideneamino)-2-imidazolidinethiones

Also Published As

Publication number Publication date
FR1550961A (en, 2012) 1968-12-27
FI45556B (en, 2012) 1972-04-04
DK116509B (da) 1970-01-19
CH483446A (de) 1969-12-31
FI45556C (fi) 1972-07-10
BR6682681D0 (pt) 1973-11-13
DE1620093A1 (de) 1970-02-26
IL26182A (en) 1970-02-19
NL6612588A (en, 2012) 1967-03-08
GB1097359A (en) 1968-01-03
SE303758B (en, 2012) 1968-09-09
NO118068B (en, 2012) 1969-11-03
US3415821A (en) 1968-12-10
NL147434B (nl) 1975-10-15
BE686434A (en, 2012) 1967-03-06

Similar Documents

Publication Publication Date Title
AT303033B (de) Verfahren zur Herstellung von neuen 1-(1,3,4-Thiadiazol-2-yl)-imidazolidinon-(2)-Derivaten
CH481135A (de) Verfahren zur Herstellung von 5-substituierten 6-Aza-2'-desoxyuridinen
AT263759B (de) Verfahren zur Herstellung von neuen 1-[(5-substituierten)-Furfurylidenamino]-hydantoinen oder -imidazolidonen
AT269106B (de) Verfahren zur Herstellung von neuen 1-(m-Hydroxyphenyl)-2-aminomethyl-cycloalkenen
CH499542A (de) Verfahren zur Herstellung von neuen Imidazolidinonderivaten
AT289756B (de) Verfahren zur Herstellung von neuen 1-(m-Hydroxyphenyl)-2-aminoalkanen
AT284829B (de) Verfahren zur Herstellung von neuen 4-(Hydro-anilino)-2-(5-nitro-2-furyl)-chinazolinen
CH476735A (de) Verfahren zur Herstellung von neuen 2-Mercaptoimidazolderivaten
AT299213B (de) Verfahren zur Herstellung von neuen 2-(Dioxo-piperazino)-benzophenonen
CH473829A (de) Verfahren zur Herstellung von neuen heterocyclischen Aminen
CH459222A (de) Verfahren zur Herstellung von neuen heterocyclischen Sulfonylharnstoff-Derivaten
AT300781B (de) Verfahren zur Herstellung von neuen N-(2-Tetrahydrofuryl)-alkylphthalimiden
AT312171B (de) Verfahren zur Herstellung von neuen Imidazolribosylcyclophosphaten
CH445505A (de) Verfahren zur Herstellung von neuen s-Triazinen
AT257596B (de) Verfahren zur Herstellung von neuen 1,2,4-Triazolderivaten
AT259565B (de) Verfahren zur Herstellung von neuen Benzodiazepin-Derivaten
AT267519B (de) Verfahren zur Herstellung von neuen Benzimidazolderivaten
CH456604A (de) Verfahren zur Herstellung von neuen heterocyclischen Sulfonylharnstoff-Derivaten
CH541568A (de) Verfahren zur Herstellung von neuen Imidazolidinonderivaten
AT265280B (de) Verfahren zur Herstellung von neuen Hexahydropyrimidinderivaten
CH487910A (de) Verfahren zur Herstellung von neuen heterocyclischen substituierten Monohalogen-1,3,5-triazinen
AT308763B (de) Verfahren zur Herstellung von neuen 1-substituierten 3-(2-Pyrimidyl)-harnstoffen
AT258304B (de) Verfahren zur Herstellung von neuen 2-Azetidinonderivaten
AT270638B (de) Verfahren zur Herstellung von neuen substituierten Benzimidazolen
AT263795B (de) Verfahren zur Herstellung von neuen heterocyclischen Sulfonylharnstoffderivaten